DE2305092A1
(de)
|
1972-02-05 |
1973-08-16 |
Yamanouchi Pharma Co Ltd |
Alpha-aminomethylbenzylalkoholderivate
|
US3994974A
(en)
|
1972-02-05 |
1976-11-30 |
Yamanouchi Pharmaceutical Co., Ltd. |
α-Aminomethylbenzyl alcohol derivatives
|
SE378109B
(US07541385-20090602-C00001.png)
|
1972-05-19 |
1975-08-18 |
Bofors Ab |
|
PH24267A
(en)
|
1980-02-15 |
1990-05-29 |
Glaxo Group Ltd |
Androstane carbothioates and pharmaceutical compositions containing the same
|
US4578221A
(en)
*
|
1980-04-23 |
1986-03-25 |
Glaxo Group Limited |
Androstane carbothioic acids
|
ZW6584A1
(en)
|
1983-04-18 |
1985-04-17 |
Glaxo Group Ltd |
Phenethanolamine derivatives
|
US4826689A
(en)
*
|
1984-05-21 |
1989-05-02 |
University Of Rochester |
Method for making uniformly sized particles from water-insoluble organic compounds
|
GB8630913D0
(en)
*
|
1986-12-24 |
1987-02-04 |
Glaxo Group Ltd |
Pharmaceutical compositions
|
US5052558A
(en)
|
1987-12-23 |
1991-10-01 |
Entravision, Inc. |
Packaged pharmaceutical product
|
US5033252A
(en)
|
1987-12-23 |
1991-07-23 |
Entravision, Inc. |
Method of packaging and sterilizing a pharmaceutical product
|
GB8825892D0
(en)
|
1988-11-04 |
1988-12-07 |
Fisons Plc |
Pharmaceutical composition
|
US5290815A
(en)
|
1989-09-07 |
1994-03-01 |
Glaxo Group Limited |
Treatment of inflammation and allergy
|
US5270305A
(en)
|
1989-09-08 |
1993-12-14 |
Glaxo Group Limited |
Medicaments
|
SE8903219D0
(sv)
|
1989-10-02 |
1989-10-02 |
Astra Ab |
Process for the manufacture of budesonide
|
US5126123A
(en)
*
|
1990-06-28 |
1992-06-30 |
Glaxo, Inc. |
Aerosol drug formulations
|
CA2068329C
(en)
|
1990-09-18 |
1998-10-13 |
Ronald James Kadlec |
Digital servo control system for use in disk drives
|
US5434304A
(en)
*
|
1990-09-26 |
1995-07-18 |
Aktiebolaget Astra |
Process for preparing formoterol and related compounds
|
SE9003057D0
(sv)
|
1990-09-26 |
1990-09-26 |
Astra Ab |
New process
|
US5785952A
(en)
*
|
1990-11-09 |
1998-07-28 |
Glaxo Group Limited |
Aerosol medicament formulation having a surface coating of surfactant
|
US5919435A
(en)
*
|
1990-11-09 |
1999-07-06 |
Glaxo Group Limited |
Aerosol formulation containing a particulate medicament
|
US5552160A
(en)
*
|
1991-01-25 |
1996-09-03 |
Nanosystems L.L.C. |
Surface modified NSAID nanoparticles
|
US5145684A
(en)
*
|
1991-01-25 |
1992-09-08 |
Sterling Drug Inc. |
Surface modified drug nanoparticles
|
NZ241954A
(en)
*
|
1991-03-15 |
1994-01-26 |
Amgen Inc |
Compositions of g-csf for pulmonary administration.
|
US5795564A
(en)
|
1991-04-05 |
1998-08-18 |
Sepracor, Inc. |
Methods and compositions for treating pulmonary disorders using optically pure (R,R)-formoterol
|
US5874063A
(en)
|
1991-04-11 |
1999-02-23 |
Astra Aktiebolag |
Pharmaceutical formulation
|
SE9302777D0
(sv)
*
|
1993-08-27 |
1993-08-27 |
Astra Ab |
Process for conditioning substances
|
CA2455115C
(en)
|
1991-12-12 |
2008-05-27 |
Glaxo Group Limited |
Pharmaceutical aerosol formulation
|
US5658549A
(en)
*
|
1991-12-12 |
1997-08-19 |
Glaxo Group Limited |
Aerosol formulations containing propellant 134a and fluticasone propionate
|
AU663906B2
(en)
|
1991-12-12 |
1995-10-26 |
Glaxo Group Limited |
Medicaments
|
US5736124A
(en)
*
|
1991-12-12 |
1998-04-07 |
Glaxo Group Limited |
Aerosol formulations containing P134a and particulate medicament
|
IL104068A
(en)
|
1991-12-12 |
1998-10-30 |
Glaxo Group Ltd |
Pharmaceutical preparations in a spray without surfactant containing 1, 1, 1, 2 tetrafluoroethane or 1,1,2,3,3 petafluor N propane as propellant
|
US5916540A
(en)
*
|
1994-10-24 |
1999-06-29 |
Glaxo Group Limited |
Aerosol formulations containing P134A and/or P227 and particulate medicament
|
JP3342484B2
(ja)
|
1991-12-18 |
2002-11-11 |
アストラ・アクチエボラーグ |
新規な配合
|
US5323907A
(en)
|
1992-06-23 |
1994-06-28 |
Multi-Comp, Inc. |
Child resistant package assembly for dispensing pharmaceutical medications
|
US5376359A
(en)
*
|
1992-07-07 |
1994-12-27 |
Glaxo, Inc. |
Method of stabilizing aerosol formulations
|
NZ263084A
(en)
|
1993-03-12 |
1997-08-22 |
Arris Pharm Corp |
Dipeptide derivatives, treatment of immunomediated inflammatory disorders
|
TW385308B
(en)
|
1994-03-04 |
2000-03-21 |
Merck & Co Inc |
Prodrugs of morpholine tachykinin receptor antagonists
|
GB9404945D0
(en)
*
|
1994-03-15 |
1994-04-27 |
Glaxo Group Ltd |
Pharmaceutical composition
|
GB9410222D0
(en)
|
1994-05-21 |
1994-07-06 |
Glaxo Wellcome Australia Ltd |
Medicaments
|
US5602110A
(en)
|
1994-08-31 |
1997-02-11 |
Case Western Reserve University |
Method and composition for treating cystic fibrosis
|
GB9419536D0
(en)
*
|
1994-09-28 |
1994-11-16 |
Glaxo Inc |
Medicaments
|
SE9700134D0
(sv)
|
1997-01-20 |
1997-01-20 |
Astra Ab |
New formulation
|
US5980949A
(en)
|
1994-10-03 |
1999-11-09 |
Astra Aktiebolag |
Formulation for inhalation
|
US5983956A
(en)
|
1994-10-03 |
1999-11-16 |
Astra Aktiebolag |
Formulation for inhalation
|
US5647347A
(en)
*
|
1994-10-21 |
1997-07-15 |
Glaxo Wellcome Inc. |
Medicament carrier for dry powder inhalator
|
DE19541689A1
(de)
|
1994-11-14 |
1996-05-15 |
Byk Gulden Lomberg Chem Fab |
Kombinationsarzneimittel
|
GB9425160D0
(en)
|
1994-12-10 |
1995-02-08 |
Glaxo Group Ltd |
Medicaments
|
NZ298169A
(en)
|
1994-12-22 |
1999-09-29 |
Astra Ab |
Aerosol drug formulation; comprises hydrofluoroalkane propellant, medicament for inhalation and a surfactant
|
GB9426252D0
(en)
*
|
1994-12-24 |
1995-02-22 |
Glaxo Group Ltd |
Pharmaceutical composition
|
DZ1965A1
(fr)
*
|
1995-02-06 |
2002-07-17 |
Astra Ab |
Composition pharmaceutique nouvelle.
|
US5510118A
(en)
*
|
1995-02-14 |
1996-04-23 |
Nanosystems Llc |
Process for preparing therapeutic compositions containing nanoparticles
|
SE9501384D0
(sv)
|
1995-04-13 |
1995-04-13 |
Astra Ab |
Process for the preparation of respirable particles
|
GB9507768D0
(en)
|
1995-04-13 |
1995-05-31 |
Glaxo Group Ltd |
Method of apparatus
|
EE04004B1
(et)
|
1995-04-14 |
2003-04-15 |
Glaxo Wellcome Inc. |
Flutikasoonpropionaati doseeriv inhalaator
|
US5677280A
(en)
|
1995-06-07 |
1997-10-14 |
Glaxo Group Limited |
Peptides and compounds that bind to the IL-5 receptor
|
US5683983A
(en)
|
1995-06-07 |
1997-11-04 |
Glaxo Group Limited |
Peptides and compounds that bind to the IL-5 receptor
|
US5874481A
(en)
|
1995-06-07 |
1999-02-23 |
Alliance Pharmaceutical Corp. |
Fluorochemical solutions for the delivery of lipophilic pharmaceutical agents
|
US5668110A
(en)
|
1995-06-07 |
1997-09-16 |
Affymax Technologies N.V. |
Peptides and compounds that bind to the IL-5 receptor
|
US5654276A
(en)
|
1995-06-07 |
1997-08-05 |
Affymax Technologies N.V. |
Peptides and compounds that bind to the IL-5 receptor
|
US6041777A
(en)
|
1995-12-01 |
2000-03-28 |
Alliance Pharmaceutical Corp. |
Methods and apparatus for closed-circuit ventilation therapy
|
US5733526A
(en)
|
1995-12-14 |
1998-03-31 |
Alliance Pharmaceutical Corp. |
Hydrocarbon oil/fluorochemical preparations and methods of use
|
US5753218A
(en)
*
|
1996-05-03 |
1998-05-19 |
Schering Corporation |
Method for treating inflammation
|
GB9612297D0
(en)
|
1996-06-11 |
1996-08-14 |
Minnesota Mining & Mfg |
Medicinal aerosol formulations
|
GB9616237D0
(en)
|
1996-08-01 |
1996-09-11 |
Norton Healthcare Ltd |
Aerosol formulations
|
SE9603669D0
(sv)
|
1996-10-08 |
1996-10-08 |
Astra Ab |
New combination
|
US5750549A
(en)
|
1996-10-15 |
1998-05-12 |
Merck & Co., Inc. |
Cycloalkyl tachykinin receptor antagonists
|
GB9622173D0
(en)
|
1996-10-24 |
1996-12-18 |
Glaxo Group Ltd |
Particulate Products
|
US5929094A
(en)
|
1996-10-25 |
1999-07-27 |
Merck & Co., Inc. |
Heteroaryl spiroethercycloalkyl tachykinin receptor antagonists
|
GB9625843D0
(en)
|
1996-12-12 |
1997-01-29 |
Merck & Co Inc |
Phenyl spiroethercycloalkyl tachykinn receptor antagonists
|
US6040344A
(en)
*
|
1996-11-11 |
2000-03-21 |
Sepracor Inc. |
Formoterol process
|
US6413496B1
(en)
|
1996-12-04 |
2002-07-02 |
Biogland Ireland (R&D) Limited |
Pharmaceutical compositions and devices for their administration
|
SE9604486D0
(sv)
|
1996-12-05 |
1996-12-05 |
Astra Ab |
Novel formulation
|
FR2756739B1
(fr)
|
1996-12-05 |
2000-04-28 |
Astra Ab |
Nouvelle formulation de budesonide
|
AU5719798A
(en)
*
|
1996-12-31 |
1998-07-31 |
Inhale Therapeutic Systems, Inc. |
Processes for spray drying aqueous suspensions of hydrophobic drugs with hydrophilic excipients and compositions prepared by such processes
|
SE9700135D0
(sv)
|
1997-01-20 |
1997-01-20 |
Astra Ab |
New formulation
|
SE9700133D0
(sv)
*
|
1997-01-20 |
1997-01-20 |
Astra Ab |
New formulation
|
WO1998034595A1
(de)
|
1997-02-05 |
1998-08-13 |
Jago Research Ag |
Medizinische aerosolformulierungen
|
US6126919A
(en)
|
1997-02-07 |
2000-10-03 |
3M Innovative Properties Company |
Biocompatible compounds for pharmaceutical drug delivery systems
|
US6268479B1
(en)
*
|
1997-03-12 |
2001-07-31 |
The Trustees Of Columbia University In The City Of New York |
Intracellular amyloid-beta peptide binding (ERAB) polypeptide
|
HU226671B1
(en)
|
1997-03-20 |
2009-06-29 |
Schering Corp |
Preparation of powder agglomerates
|
US6503537B2
(en)
|
1997-03-20 |
2003-01-07 |
Schering Corporation |
Preparation of powder agglomerates
|
DE69837664T2
(de)
|
1997-05-14 |
2008-01-03 |
Senju Pharmaceutical Co., Ltd. |
Wässrige suspensionspräparationen mit exzellenter redispersibilität
|
SE9701956D0
(sv)
|
1997-05-23 |
1997-05-23 |
Astra Ab |
New composition of matter
|
BR9810452A
(pt)
|
1997-06-27 |
2000-09-05 |
Astra Ab |
Nova combinação de medicamentos contra asma
|
US20010044584A1
(en)
|
1997-08-28 |
2001-11-22 |
Kensey Kenneth R. |
In vivo delivery methods and compositions
|
SE9703407D0
(sv)
|
1997-09-19 |
1997-09-19 |
Astra Ab |
New use
|
US6309623B1
(en)
|
1997-09-29 |
2001-10-30 |
Inhale Therapeutic Systems, Inc. |
Stabilized preparations for use in metered dose inhalers
|
EP1021172B1
(en)
*
|
1997-10-08 |
2002-04-10 |
Sepracor, Inc. |
Dosage form for aerosol administration
|
US5972327A
(en)
*
|
1997-10-22 |
1999-10-26 |
Lin; Matthew M. |
Method of treating allergic rhinitis by delivering medication via the nasal vestibules
|
SE9704186D0
(sv)
|
1997-11-14 |
1997-11-14 |
Astra Ab |
New composition of matter
|
SE9704644D0
(sv)
|
1997-12-12 |
1997-12-12 |
Astra Ab |
New use
|
US6598603B1
(en)
|
1997-12-31 |
2003-07-29 |
Astra Aktiebolag |
Method for treating respiratory diseases
|
US20020010197A1
(en)
|
1998-01-13 |
2002-01-24 |
John Dixon |
Pharmaceutical compositions comprising a compound having dopamine (d2) receptor agonist activity and a compound (b) having beta2-adrenoreceptor agonist activity
|
CA2320104A1
(en)
|
1998-02-10 |
1999-08-19 |
Cangene Corporation |
Method for the prevention and treatment of a type i hypersensitivity disorder
|
US5972920A
(en)
*
|
1998-02-12 |
1999-10-26 |
Dermalogix Partners, Inc. |
Formulation containing a carrier, active ingredient, and surfactant for treating skin disorders
|
US6287693B1
(en)
|
1998-02-25 |
2001-09-11 |
John Claude Savoir |
Stable shaped particles of crystalline organic compounds
|
GB9806462D0
(en)
|
1998-03-26 |
1998-05-27 |
Glaxo Group Ltd |
Improved compositions for inhalation
|
SE9801368D0
(sv)
|
1998-04-20 |
1998-04-20 |
Astra Ab |
New use
|
US5993782A
(en)
*
|
1998-04-28 |
1999-11-30 |
Gardner; Conrad O. |
Therapeutic method for reversing hyposmia in a human patient
|
DE29923848U1
(de)
|
1998-05-27 |
2001-04-12 |
Euro Celtique Sa |
Präparate zur Anwendung von entzündungshemmenden, insbesondere antiseptischen Wirkstoffen und/oder die Wundheilung fördernden Wirkstoffen in den oberen Atemwegen und/oder dem Ohr
|
SE9802073D0
(sv)
|
1998-06-11 |
1998-06-11 |
Astra Ab |
New use
|
US6423298B2
(en)
|
1998-06-18 |
2002-07-23 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Pharmaceutical formulations for aerosols with two or more active substances
|
EP1087750B1
(en)
|
1998-06-18 |
2003-11-12 |
Boehringer Ingelheim Pharmaceuticals Inc. |
Pharmaceutical formulations for aerosols with two or more active substances
|
US5965622A
(en)
|
1998-06-23 |
1999-10-12 |
Sepracor Inc. |
Desformoterol and process for its preparation
|
US6241969B1
(en)
|
1998-06-26 |
2001-06-05 |
Elan Corporation Plc |
Aqueous compositions containing corticosteroids for nasal and pulmonary delivery
|
GB9815614D0
(en)
|
1998-07-18 |
1998-09-16 |
Hoodco 446 Limited |
A mirror arrangement for a rear view mirror system in an article of headgear
|
ES2234266T3
(es)
|
1998-07-24 |
2005-06-16 |
Jago Research Ag |
Formulaciones medicas para aerosoles.
|
EP1102579B1
(de)
|
1998-08-04 |
2003-03-19 |
Jago Research Ag |
Medizinische aerosolformulierungen
|
DE19835346A1
(de)
|
1998-08-05 |
2000-02-10 |
Boehringer Ingelheim Pharma |
Zweiteilige Kapsel zur Aufnahme von pharmazeutischen Zubereitungen für Pulverinhalatoren
|
US6112924A
(en)
*
|
1998-09-10 |
2000-09-05 |
Bcb Usa, Inc. |
Container with base having cylindrical legs with circular feet
|
US6136294C1
(en)
|
1998-09-22 |
2002-09-24 |
Aeropharm Technology Inc |
Amino acid stabilized medical aerosol formulation
|
DE19847970A1
(de)
|
1998-10-17 |
2000-04-20 |
Boehringer Ingelheim Pharma |
Lagerfähige Wirkstoff-Formulierung
|
DE19847969A1
(de)
*
|
1998-10-17 |
2000-04-20 |
Boehringer Ingelheim Pharma |
Lagerfähig flüssige Formulierung mit Formoterol
|
DE19847968A1
(de)
|
1998-10-17 |
2000-04-20 |
Boehringer Ingelheim Pharma |
Verschlußkappe und Behälter als Zweikammer-Kartusche für Vernebler zur Erzeugung von Aerosolen
|
EE04219B1
(et)
|
1998-10-17 |
2004-02-16 |
Boehringer Ingelheim Pharma Kg |
Säilituskindel toimeainekontsentraat formoterooliga
|
US6235725B1
(en)
|
1998-10-30 |
2001-05-22 |
Baker Norton Pharmaceuticals, Inc. |
Methods and compositions for the prevention of tolerance to medications
|
IT1303692B1
(it)
|
1998-11-03 |
2001-02-23 |
Chiesi Farma Spa |
Procedimento per la preparazione di sospensioni di particelle difarmaci da somministrare per inalazione.
|
EP1862164A3
(de)
|
1998-11-13 |
2012-12-26 |
Jagotec AG |
Trockenpulver zur Inhalation
|
SE9804003D0
(sv)
|
1998-11-23 |
1998-11-23 |
Astra Ab |
A method of producing drug particles
|
US6261539B1
(en)
|
1998-12-10 |
2001-07-17 |
Akwete Adjei |
Medicinal aerosol formulation
|
US6004537A
(en)
|
1998-12-18 |
1999-12-21 |
Baker Norton Pharmaceuticals, Inc. |
Pharmaceutical solution aerosol formulations containing fluoroalkanes, budesonide and formoterol
|
IL128045A0
(en)
|
1999-01-14 |
1999-11-30 |
Dip Digital Power Ltd |
Method and device for obtaining a fractional voltage from an a.c. voltage source
|
GB9903759D0
(en)
|
1999-02-18 |
1999-04-14 |
Novartis Ag |
Organic compounds
|
US6716452B1
(en)
|
2000-08-22 |
2004-04-06 |
New River Pharmaceuticals Inc. |
Active agent delivery systems and methods for protecting and administering active agents
|
US6136603A
(en)
|
1999-03-26 |
2000-10-24 |
Isis Pharmaceuticals Inc. |
Antisense modulation of interleukin-5 signal transduction
|
US6303145B2
(en)
*
|
1999-05-10 |
2001-10-16 |
Sepracor Inc. |
(S,R) formoterol methods and compositions
|
US20020081266A1
(en)
|
1999-08-20 |
2002-06-27 |
Norton Healthcare Ltd. |
Spray dried powders for pulmonary or nasal administration
|
EP1143930B8
(en)
|
1999-09-11 |
2008-03-19 |
Glaxo Group Limited |
Pharmaceutical formulation of fluticasone propionate
|
US6816510B1
(en)
|
2000-02-09 |
2004-11-09 |
Koninklijke Philips Electronics N.V. |
Method for clock synchronization between nodes in a packet network
|
US6369115B1
(en)
|
2000-03-20 |
2002-04-09 |
Dura Pharmaceuticals, Inc. |
Stabilized powder formulations
|
JP2001292372A
(ja)
*
|
2000-04-04 |
2001-10-19 |
Pioneer Electronic Corp |
画像変化検出装置及び画像変化検出方法、画像符号化装置並びに画像変化検出用プログラムがコンピュータで読取可能に記録された情報記録媒体
|
PL358375A1
(en)
|
2000-04-13 |
2004-08-09 |
Innovata Biomed Limited |
Medicaments for treating respiratory disorders comprising formoterol and fluticasone
|
GB0009584D0
(en)
*
|
2000-04-18 |
2000-06-07 |
Glaxo Group Ltd |
Pharmaceutical compositions
|
GB0012260D0
(en)
|
2000-05-19 |
2000-07-12 |
Astrazeneca Ab |
Novel composition
|
HU230804B1
(hu)
|
2000-05-22 |
2018-06-28 |
Chiesi Farmaceutici S.P.A |
Gyógyászati célú stabil aeroszol összetétel, inhalátor az aeroszol pontos adagolásához és eljárás ennek feltöltésére
|
US6451287B1
(en)
|
2000-05-26 |
2002-09-17 |
Smithkline Beecham Corporation |
Fluorinated copolymer surfactants and use thereof in aerosol compositions
|
SE0002822L
(sv)
|
2000-08-04 |
2002-01-29 |
Microdrug Ag |
Elektropulver
|
US20020099013A1
(en)
|
2000-11-14 |
2002-07-25 |
Thomas Piccariello |
Active agent delivery systems and methods for protecting and administering active agents
|
FI20002177A0
(fi)
|
2000-10-02 |
2000-10-02 |
Orion Yhtymae Oyj |
Uusi yhdistelmä astman hoitoon
|
ATE320242T1
(de)
|
2000-10-09 |
2006-04-15 |
3M Innovative Properties Co |
Medizinische aerosolzusammensetzung
|
ES2227268T3
(es)
*
|
2000-10-12 |
2005-04-01 |
BOEHRINGER INGELHEIM PHARMA GMBH & CO.KG |
Nuevos polvos para inhalacion con contenido en tiotropio.
|
US6884782B2
(en)
|
2000-11-08 |
2005-04-26 |
Amgen Inc. |
STAT modulators
|
AU2002226986A1
(en)
|
2000-12-01 |
2002-06-11 |
Rheologics, Inc. |
In vivo delivery methods and compositions
|
GB0030074D0
(en)
|
2000-12-08 |
2001-01-24 |
Univ London Pharmacy |
Particulate inhalation carrier
|
SE0004750D0
(sv)
|
2000-12-19 |
2000-12-19 |
Astrazeneca Ab |
Novel formulation
|
DE60203652T2
(de)
|
2001-01-31 |
2005-09-08 |
Pfizer Products Inc., Groton |
Nikotinsäureamid-Derivate und ihre Mimetika als Inhibitoren von PDE4-Isozyme
|
ITMI20010428A1
(it)
|
2001-03-02 |
2002-09-02 |
Chemo Breath S A |
Composizioni ad uso inalatorio a base di formoterolo
|
US6667344B2
(en)
|
2001-04-17 |
2003-12-23 |
Dey, L.P. |
Bronchodilating compositions and methods
|
US20030055026A1
(en)
|
2001-04-17 |
2003-03-20 |
Dey L.P. |
Formoterol/steroid bronchodilating compositions and methods of use thereof
|
KR100422250B1
(ko)
*
|
2001-08-21 |
2004-03-11 |
삼성전자주식회사 |
휴대용 컴퓨터
|
PL208686B1
(pl)
*
|
2001-09-18 |
2011-05-31 |
Nycomed Danmark Aps |
Kompozycja w postaci roztworu wodnego do leczenia przeziębienia oraz zastosowanie połączenia ipratropium lub jego soli i ksylometazoliny lub jej soli
|
JP2003221335A
(ja)
|
2001-10-26 |
2003-08-05 |
Dey Lp |
慢性閉塞性肺疾患の症状を緩和するためのアルブテロールおよびイプラトロピウム吸入溶液、システム、キットおよび方法
|
US6702997B2
(en)
|
2001-10-26 |
2004-03-09 |
Dey, L.P. |
Albuterol inhalation solution, system, kit and method for relieving symptoms of pediatric asthma
|
GB0129395D0
(en)
*
|
2001-12-07 |
2002-01-30 |
Pfizer Ltd |
Pharmaceutical combination
|
US20040023935A1
(en)
|
2002-08-02 |
2004-02-05 |
Dey, L.P. |
Inhalation compositions, methods of use thereof, and process for preparation of same
|
US20040110845A1
(en)
|
2002-12-06 |
2004-06-10 |
Ramana Malladi |
Stabilized albuterol compositions and method of preparation thereof
|
US20040109826A1
(en)
|
2002-12-06 |
2004-06-10 |
Dey, L.P. |
Stabilized albuterol compositions and method of preparation thereof
|
TWI359675B
(en)
|
2003-07-10 |
2012-03-11 |
Dey L P |
Bronchodilating β-agonist compositions
|